================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report: August 15, 2007
(Date of Earliest Event Reported: August 15, 2007)
----------------------
RADNET, INC.
(Exact name of registrant as specified in its Charter)
New York 0-19019 13-3326724
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
1510 Cotner Avenue
Los Angeles, California 90025
(Address of Principal Executive Offices) (Zip Code)
(310) 478-7808
(Registrant's Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b) )
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c) )
ITEM 8.01. OTHER EVENTS
Attached hereto as Exhibit 99.1 and incorporated herein by reference is
the text of a conference call and series of questions recently posed to the
Registrant by certain of its investors and other members of the investment
community, and the Registrant's responses thereto.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits
Exhibit Number Description of Exhibit
99.1 Discussion, Questions and Answers.
-2-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: August 15, 2007 RADNET, INC.
By: /s/ Howard G. Berger, M.D.
-----------------------------
Howard G. Berger, M.D.
President and Chief Executive Officer
-3-
EXHIBIT INDEX
99.1 Discussion, Questions and Answers
-4-